The 6 analysts offering 12-month price forecasts for Bio Rad Laboratories Inc have a median target of 440.50, with a high estimate of 482.00 and a low estimate of 350.00. The median estimate represents a +44.62% increase from the last price of 304.59.
The current consensus among 7 polled investment analysts is to Buy stock in Bio Rad Laboratories Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $4.39
Reporting Date Feb 08
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.